Search Results - Zildjian, Sybil

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study

    Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable... by Oaknin, Ana, Gilbert, Lucy, Tinker, Anna V, Brown, Jubilee, Mathews, Cara, Press, Joshua, Sabatier, Renaud, O’Malley, David M, Samouelian, Vanessa, Boni, Valentina, Duska, Linda, Ghamande, Sharad, Ghatage, Prafull, Kristeleit, Rebecca, Leath III, Charles, Guo, Wei, Im, Ellie, Zildjian, Sybil, Han, Xinwei, Duan, Tao, Veneris, Jennifer, Pothuri, Bhavana

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A Phase I Study of IMGN529, an Antibody-Drug Conjugate (ADC) Targeting CD37, in Adult Patients with Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma (NHL)

    A Phase I Study of IMGN529, an Antibody-Drug Conjugate (ADC) Targeting CD37, in Adult Patients with Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma (NHL) by Stathis, Anastasios, Freedman, Arnold S., Flinn, Ian W., Maddocks, Kami J., Weitman, Steven, Berdeja, Jesus G., Mejia, Alex V., Zucca, Emanuele, Green, Rebecca, Romanelli, Angela, Zildjian, Sybil H, Ruiz-Soto, Rodrigo, Palomba, Lia

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Phase I Study of Lorvotuzumab Mertansine (IMGN901) In Combination with Lenalidomide and Dexamethasone In Patients with CD56-Positive Relapsed or Relapsed/Refractory Mulitple Myeloma - A Preliminary Safety and Efficacy Analysis of the Combination

    Phase I Study of Lorvotuzumab Mertansine (IMGN901) In Combination with Lenalidomide and Dexamethasone In Patients with CD56-Positive Relapsed or Relapsed/Refractory Mulitple Myelom... by Berdeja, Jesus G, Ailawadhi, Sikander, Niesvizky, Ruben, Wolf, Jeffrey L, Zildjian, Sybil H, O'Leary, James, Chanan-Khan, Asher

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Efficacy Analysis From Phase I Study of Lorvotuzumab Mertansine (IMGN901), Used as Monotherapy, In Patients with Heavily Pre-Treated CD56-Positive Multiple Myeloma - A Preliminary Efficacy Analysis

    Efficacy Analysis From Phase I Study of Lorvotuzumab Mertansine (IMGN901), Used as Monotherapy, In Patients with Heavily Pre-Treated CD56-Positive Multiple Myeloma - A Preliminary... by Chanan-Khan, Asher, Wolf, Jeffrey L, Garcia, Juan, Gharibo, Mecide, Jagannath, Sundar, Manfredi, Debbie, Sher, Taimur, Martin, Cindi, Zildjian, Sybil H, O'Leary, James, Vescio, Robert

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Phase I Study of IMGN901, Used as Monotherapy, in Patients with Heavily Pre-Treated CD56-Positive Multiple Myeloma - A Preliminary Safety and Efficacy Analysis

    Phase I Study of IMGN901, Used as Monotherapy, in Patients with Heavily Pre-Treated CD56-Positive Multiple Myeloma - A Preliminary Safety and Efficacy Analysis by Chanan-Khan, Asher, Wolf, Jeffrey, Gharibo, Mecide, Jagannath, Sundar, Munshi, Nikhil C., Anderson, Kenneth C., Manfredi, Debbie, Lee, Kelvin P., Miller, Kena C, Guild, Robin, Zildjian, Sybil, Qin, Albert, O'Leary, James, Vescio, Robert

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Phase I Study of IMGN901 in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma

    Phase I Study of IMGN901 in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma by Chanan-Khan, Asher Alban, Gharibo, Mecide, Jagannath, Sundar, Munshi, Nikhil C., Anderson, Kenneth C, DePaolo, Dawn, Lee, Kelvin P., Miller, Kena, Guild, Robin, Zildjian, Sybil, Qin, Albert

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Phase I Study of huN901-DM1 (BB-10901) in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma

    Phase I Study of huN901-DM1 (BB-10901) in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma by Chanan-Khan, Asher A., Jagannath, Sundar, Munshi, Nikhil C., Schlossman, Robert L., Anderson, Kenneth C., Lee, Kelvin, DePaolo, Dawn, Miller, Kena C., Zildjian, Sybil, Fram, Robert J., Qin

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: